Amgad Albohy, PhD - Publications

Affiliations: 
The British University in Egypt 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Elrazaz EZ, Serya RAT, Ismail NSM, Albohy A, Abou El Ella DA, Abouzid KAM. Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations. Bioorganic Chemistry. 113: 105019. PMID 34091286 DOI: 10.1016/j.bioorg.2021.105019  0.326
2015 Albohy A, Richards MR, Cairo CW. Mapping substrate interactions of the human membrane-associated neuraminidase, NEU3, using STD NMR. Glycobiology. 25: 284-93. PMID 25294388 DOI: 10.1093/Glycob/Cwu109  0.643
2014 Smutova V, Albohy A, Pan X, Korchagina E, Miyagi T, Bovin N, Cairo CW, Pshezhetsky AV. Structural basis for substrate specificity of mammalian neuraminidases. Plos One. 9: e106320. PMID 25222608 DOI: 10.1371/Journal.Pone.0106320  0.675
2013 Albohy A, Zhang Y, Smutova V, Pshezhetsky AV, Cairo CW. Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4. Acs Medicinal Chemistry Letters. 4: 532-7. PMID 24900705 DOI: 10.1021/Ml400080T  0.669
2013 Zhang Y, Albohy A, Zou Y, Smutova V, Pshezhetsky AV, Cairo CW. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues. Journal of Medicinal Chemistry. 56: 2948-58. PMID 23530623 DOI: 10.1021/Jm301892F  0.655
2011 Sandbhor MS, Soya N, Albohy A, Zheng RB, Cartmell J, Bundle DR, Klassen JS, Cairo CW. Substrate recognition of the membrane-associated sialidase NEU3 requires a hydrophobic aglycone. Biochemistry. 50: 6753-62. PMID 21675735 DOI: 10.1021/Bi200449J  0.683
2011 Albohy A, Mohan S, Zheng RB, Pinto BM, Cairo CW. Inhibitor selectivity of a new class of oseltamivir analogs against viral neuraminidase over human neuraminidase enzymes. Bioorganic & Medicinal Chemistry. 19: 2817-22. PMID 21489803 DOI: 10.1016/J.Bmc.2011.03.039  0.69
2010 Zou Y, Albohy A, Sandbhor M, Cairo CW. Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid. Bioorganic & Medicinal Chemistry Letters. 20: 7529-33. PMID 21036040 DOI: 10.1016/J.Bmcl.2010.09.111  0.665
2010 Albohy A, Li MD, Zheng RB, Zou C, Cairo CW. Insight into substrate recognition and catalysis by the human neuraminidase 3 (NEU3) through molecular modeling and site-directed mutagenesis. Glycobiology. 20: 1127-38. PMID 20511247 DOI: 10.1093/Glycob/Cwq077  0.69
2010 Cairo CW, Das R, Albohy A, Baca QJ, Pradhan D, Morrow JS, Coombs D, Golan DE. Dynamic regulation of CD45 lateral mobility by the spectrin-ankyrin cytoskeleton of T cells. The Journal of Biological Chemistry. 285: 11392-401. PMID 20164196 DOI: 10.1074/Jbc.M109.075648  0.514
2009 Ismail MAH, Lehmann J, Ella DAAE, Albohy A, Abouzid KAM. Lonazolac analogues: molecular modeling, synthesis, and in vivo anti-inflammatory activity Medicinal Chemistry Research. 18: 725-744. DOI: 10.1007/S00044-009-9163-2  0.395
Show low-probability matches.